Investing.com -- Morgan Stanley outlined two stocks as its top picks in the European chemicals sector, highlighting their defensive qualities and growth potential despite an otherwise challenging outlook for the industry.
The investment bank’s analysis points to these companies’ ability to maintain earnings resilience amid subdued demand conditions that have affected the broader chemicals industry. Both stocks offer investors exposure to specialty segments with stronger barriers to entry and more stable end markets compared to cyclical industrial chemicals.
International Flavors & Fragrances (
Morgan Stanley chose IFF as a top pick, lauding its exposure to consumer ingredients rather than more cyclical industrial chemicals. The bank expects IFF’s earnings to remain resilient despite the current subdued demand environment, supported by pricing discipline, portfolio optimization efforts, and high exposure to recurring end-markets including food, beverage, and personal care products.
Analysts see limited downside risk to consensus forecasts for IFF, noting that volumes are holding up better than in industrial chemicals while margins benefit from ongoing cost management initiatives. Morgan Stanley also pointed to IFF’s attractive valuation following a sector-wide de-rating, suggesting the company offers an appealing combination of defensive characteristics and operational leverage when demand conditions eventually improve.
In a recent development, International Flavors & Fragrances reported third-quarter 2025 results that surpassed analyst expectations, with revenue of $2.69 billion and earnings per share of $1.05.
Syensqo
Morgan Stanley’s second top pick, Syensqo, earned its recommendation based on the company’s focus on higher-quality specialty polymers and materials with strong barriers to entry. The bank identifies return on invested capital as a key driver of valuation and believes Syensqo is well-positioned versus peers on this important metric.
Despite weak industrial demand, Morgan Stanley expects Syensqo to deliver relatively stable earnings, supported by exposure to structurally growing applications and limited competitive pressure from Chinese manufacturers in advanced specialties. The bank also notes that supply growth in key chains is set to abate, which should support margins. Syensqo’s portfolio mix is seen as offering leverage to a recovery without excessive cyclicality.
Syensqo announced its third-quarter 2025 results, posting net sales of €1.52 billion, which represented a slight year-on-year decrease, while achieving an EBITDA margin above 23%.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

















